Balyasny Asset Management LLC Glaukos Corp Transaction History

Balyasny Asset Management LLC

$54.9 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$76.4 - $96.33 $1 Million - $1.27 Million	-13,153 Reduced 44.16%	16,635 $1.57 Million
Q4 2023 Feb 14, 2024	SELL	$59.53 - $85.11 $3.18 Million - $4.55 Million	-53,421 Reduced 64.2%	29,788 $2.37 Million
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $5.19 Million - $5.93 Million	-74,920 Reduced 47.38%	83,209 $6.26 Million
Q2 2023 Aug 14, 2023	SELL	$45.44 - $71.21 $24.3 Million - $38 Million	-533,770 Reduced 77.15%	158,129 $11.3 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $22.9 Million - $27.3 Million	520,758 Added 304.29%	691,899 $34.7 Million
Q4 2022 Feb 14, 2023	SELL	$40.82 - $57.75 $11.4 Million - $16.1 Million	-279,134 Reduced 61.99%	171,141 $7.48 Million
Q3 2022 Nov 14, 2022	SELL	$46.84 - $58.49 $1.76 Million - $2.2 Million	-37,616 Reduced 7.71%	450,275 $24 Million
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $16.6 Million - $30.4 Million	476,273 Added 4099.44%	487,891 $22.2 Million
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $515,025 - $671,752	11,618 New	11,618 $672,000
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $17.3 Million - $24.5 Million	-430,690 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $20.4 Million - $36.3 Million	430,690 New	430,690 $20.7 Million
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $400,003 - $534,907	-5,475 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $385,604 - $533,374	5,475 New	5,475 $460,000
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $6.33 Million - $9.74 Million	-129,426 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.23 - $50.97 $570,289 - $780,758	15,318 Added 13.42%	129,426 $6.41 Million
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $3.28 Million - $5.34 Million	114,108 New	114,108 $4.38 Million
Q4 2019 Feb 14, 2020	SELL	$54.18 - $65.64 $8.61 Million - $10.4 Million	-158,827 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$58.58 - $83.91 $7.62 Million - $10.9 Million	130,011 Added 451.18%	158,827 $9.93 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $1.83 Million - $2.27 Million	28,816 New	28,816 $2.17 Million
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $11.1 Million - $14.5 Million	-213,252 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $5.66 Million - $10.2 Million	148,527 Added 229.47%	213,252 $13.8 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $1.79 Million - $2.88 Million	64,725 New	64,725 $2.63 Million

Others Institutions Holding GKOS

# of Institutions

303

Shares Held

47M

Call Options Held

75.3K

Put Options Held

157K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.11B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account